Carotid intima-media thickness (IMT): A surrogate marker of atherosclerosis

Acta Clinica Croatica

Volumn 45, Issue 1, 2006, Pages 45-51

  Rundek, Tanja ^a   Demarin, Vida ^b  

^a Columbia University in the City of New York ^*  (United States)

^b University Department of Neurology   (Croatia)

Author keywords

Arteriosclerosis diagnosis; Carotid arteries pathology; Cerebrovascular disorders etiology; Cerebrovascular disorders pathology

Indexed keywords

ALPHA TOCOPHEROL; AMLODIPINE BESYLATE; ATENOLOL; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; COLESTIPOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LACIDIPINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METOPROLOL; MEVINOLIN; NICOTINIC ACID; PLACEBO; PRAVASTATIN; RAMIPRIL; SIMVASTATIN;

ATHEROGENESIS; ATHEROSCLEROSIS; B SCAN; CAROTID ARTERIOGRAPHY; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; CLINICAL TRIAL; DISEASE COURSE; DISEASE MARKER; DOSE RESPONSE; DRUG EFFICACY; HUMAN; HYPERCHOLESTEROLEMIA; INTIMA; INTRAVASCULAR ULTRASOUND; PATHOPHYSIOLOGY; REVIEW; TREATMENT OUTCOME; TUNICA MEDIA;

EID: 33745134723     PISSN: 03539466     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. BOISSEL J-P, COLLET J-P, MOLEUR P, HAUGH M. Surrogate endpoints: a basis for a rational approach. Eur J Clin Pharmacol 1992;43:235-44.
2. DEMOL P, WEIHRAUCH TR. Surrogate endpoints: their utility for evaluating therapeutic efficacy in clinical trials. Appl Clin Trials 1998;7:45-56.
3. GLAGOV S, WEISENBERG E, ZARINS CK, STANKUN-AVICIUS R, KOLETTIS GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987;316:1371-5.
4. PROBSTFIELD JL, BYINGTON RP, EGAN DA, ESPELAND MA, MARGITIC SE, RILEY WA Jr, FURBERG CD. Methodological issues facing studies of atherosclerotic change. Circulation 1993;87:II74-II81.
5. BLANKENHORN DH, HODIS HN. Arterial imaging and atherosclerosis reversal. Arterioscler Thromb 1994;14:177-92.
6. PIGNOLI P, TREMOLI E, POLI A, ORESTE P, PAOLETTI R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986;74:1399-406.
7. POLI A, TREMOLI E, COLOMBO A, SIRTORI M, PIGNOLI P, PAOLETTI R. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients. A new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects. Atherosclerosis 1988;70:253-61.
8. th European Stroke Conference, Mannheim, Germany, May 14, 2004. Cerebrovasc Dis 2004;18:346-934.
9. O'LEARY DH, POLAK JF, KRONMAL RA, MANIOLO TA, BURKE GL, WOLFSON SK et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999;340:14-22.
10. KULLER L, BORHANI N, FURBERG C, GARDIN J, MANOLIO T, O'LEARY D et al. Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. Am J Epidemiol 1994;139:1164-79.
11. BOTS ML, HOES AW, KOUDSTAAL PJ, HOFMAN A, GROBBEE DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997;96:1432-7.
12. CHAMBLESS LE, HEISS G, FOLSOM AR, ROSAMOND W SZKLO M, SHARRETT AR et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997;146:483-94.
13. BLANKENHORN DH, SELZER RH, CRAWFORD DW, BARTH JD, LIU CR, LIU CH et al. Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound. Circulation 1993;88:20-8.
14. FURBERG CD, ADAMS HP Jr, APPLEGATE WB, BYINGTON RP, ESPELAND MA, HARTWELL T et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Circulation 1994;90:1679-87.
15. SALONEN R, NYYSSONEN K, PORKKALA E, RUMMUKAINEN J, BELDER R, PARK JS et al. Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation 1995;92:1758-64.
16. JUKEMA JW, BRUSCHKE AV, van BOVEN AJ, REIBER JH, BAL ET, ZWINDERMAN AH et al. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation 1995;91:2528-40.
17. LONN E, YUSUF S, DZAVIK V, DORIS C, YI Q, SMITH S et al. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 2001;103:919-25.
18. SMILDE TJ, van WISSEN S, WOLLERSHEIM H, TRIP MD, KASTELEIN JJ, STALENHOEF AF. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP):a prospective, randomised, double-blind trial. Lancet 2001;357(9256):577-81.
19. TAYLOR AJ, KENT SM, FLAHERTY PJ, COYLE LC, MARKWOOD TT, VERNALIS MN. ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation 2002;106:2055-60.
20. WIKLUND O, HULTHE J, WIKSTRAND J, SCHMIDT C, OLOFSSON SO, BONDJERS G. Effect of controlled release/extended release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia: a 3-year randomized study. Stroke 2002;33:572-7.
21. ZANCHETTI A, BOND MG, HENNIG M, NEISS A, MANCIA G, DAL PALU C et al. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial. Circulation 2002;106:2422-7.
22. PITT B, BYINGTON RP, FURBERG CD, HUNNINGHAKE DB, MANCINI GB, MILLER ME et al. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation 2000;102:1503-10.
23. DESVARIEUX M, DEMMER RT, RUNDEK T, B.BODEN-ALBALA B, JACOBS Jr DR, SACCO RL, PAPAPANOU PN. Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation 2005;111:576-82.
24. ELKIND MS, RUNDEK T, SCIACCA RR, RAMAS R, CHEN HJ, BODEN-ALBALA B, RABBANI L, SACCO RL. Interleukin-2 levels are associated with carotid artery intima-media thickness. Atherosclerosis 2005;180:181-7.
25. RUNDEK T, ELKIND MS, PITTMAN J, BODEN-ALBALA B, MARTIN S, HUMPHRIES SE et al. Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: the Northern Manhattan Prospective Cohort Study. Stroke 2002;33:1420-3.
26. SELZER RH, HODIS HN, KWONG-FU H, MACK WJ, LEE PL, LIU CR et al. Evaluation of computerized edge tracking for quantifying intima-media thickness of the common carotid artery from B-mode ultrasound images. Atherosclerosis 1994;111:1-11.
27. TOUBOUL PJ, PRATI P, SCARABIN PY, ADRAI V, THIBOUT E, DUCIMETIERE P. Use of monitoring software to improve the measurement of carotid wall thickness by B-mode imaging. J Hypertens Suppl 1992;10:S37-S41.
28. ZUREIK M, TOUBOUL PJ, BONITHON-KOPP C, COURBON D, BERR C, LEROUX C et al. Cross-sectional and 4-year longitudinal associations between brachial pulse pressure and common carotid intima-media thickness in a general population. The EVA study. Stroke 1999;30:550-5.
29. BALDASSARRE D, WERBA JP, TREMOLI E, POLI A, PAZZUCCONI F, SIRTORI CR. Common carotid intima-media thickness measurement. A method to improve accuracy and precision. Stroke 1994;25:1588-92.
30. RILEY WA, BARNES RW, APPLEGATE WB, DEMPSEY R, HARTWELL T, DAVIS VG et al. Reproducibility of noninvasive ultrasonic measurement of carotid atherosclerosis. The Asymptomatic Carotid Artery Plaque Study. Stroke 1992;23:1062-8.
31. BOTS ML, EVANS GW, RILEY WA, GROBEE DE. Carotid intima-media thickness measurements in intervention studies. Design options, progression rates and sample size considerations: a point of view. Stroke 2003;34:2985-94.